Maxigen Biotech Inc. · TWSE:1783

Maxigen Biotech Inc. shareholders

Maxigen Biotech Inc. on 6ix: holders from Taiwan's exchanges and US fund reports. Largest: 大江生醫股份有限公司, 台塑生醫科技股份有限公司 and 中加投資發展股份有限公司. Each with its filing.

Shareholders

Register

HolderSharesOf the companyAs of
大江生醫股份有限公司28M31.2%Oct 31, 2026
台塑生醫科技股份有限公司8.7M9.7%Oct 31, 2026
中加投資發展股份有限公司1.38M1.5%Oct 31, 2026
林詠翔588K0.66%Oct 31, 2026
陳敬亭146K0.16%Oct 31, 2026
賴柏宏85,9970.10%Oct 31, 2026
林欣榮00.00%Oct 31, 2026
吳瑞益00.00%Oct 31, 2026
曾仲銘00.00%Oct 31, 2026
李啟睿00.00%Oct 31, 2026
陳適安00.00%Oct 31, 2026
廖松淵00.00%Oct 31, 2026
賴世明00.00%Oct 31, 2026
黃振嘉00.00%Oct 31, 2026
李秋月00.00%Oct 31, 2026
大江生醫股份有限公司Nov 22, 2026

Funds

HolderSharesValueAs of
Emerging Markets Core Equity 2 Portfolio219KUS$269KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF57,000US$70,282Jul 31, 2026
The Emerging Markets Small Cap Series48,600US$59,877Jul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF36,000US$44,389Jul 31, 2026
World ex U.S. Core Equity Portfolio18,000US$22,177Jul 31, 2026
Dimensional Emerging Core Equity Market ETF14,700US$18,125Jul 31, 2026
Emerging Markets Social Core Equity Portfolio13,650US$16,817Jul 31, 2026
Emerging Markets ex China Core Equity Portfolio3,000US$3,696Jul 31, 2026

Maxigen Biotech Inc. insider trades